Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not ...
FDA Drug Recall #D-1269-2020 — Class I — April 14, 2020
Recall Summary
| Recall Number | D-1269-2020 |
| Classification | Class I — Serious risk |
| Date Initiated | April 14, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | MasterPharm LLC |
| Location | South Richmond Hill, NY |
| Product Type | Drugs |
| Quantity | 7260 capsules |
Product Description
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Reason for Recall
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Distribution Pattern
Nationwide in the U.S.
Lot / Code Information
Lot #02-27-2020:04@11, Exp. August 25, 2020.
Other Recalls from MasterPharm LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1424-2020 | Class II | Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluoc... | Jul 2, 2020 |
| D-1428-2020 | Class II | Progesterone 150 mg Troche, 30 troches MasterPh... | Jul 2, 2020 |
| D-1431-2020 | Class II | Progesterone 200 mg Troche, 30 troches per bott... | Jul 2, 2020 |
| D-1420-2020 | Class II | Estriol 6 mg Capsule, 90 capsules per bottle, M... | Jul 2, 2020 |
| D-1434-2020 | Class II | Progesterone Modified Release 200 mg Capsule, 9... | Jul 2, 2020 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.